Find Grants for Non-profits

Find out if you qualify for verified grants for Non-profits. Discover your eligibility and key funding details for Non-profits from major foundations and government agencies.

 

$ 100 Trillion
Total Dollars Available

NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional)

Deadline: October 15, 2027


Opportunity Number: PAR-25-120

Agency: National Institutes of Health

Open Date: October 18, 2024

Close Date: October 15, 2027

Status: Posted

CFDA Numbers: 93.173

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

Deadline: October 14, 2026


Opportunity Number: PAR-25-074

Agency: National Institutes of Health

Open Date: October 15, 2024

Close Date: October 14, 2026

Status: Posted

CFDA Numbers: 93.394

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)

Deadline: October 14, 2026


Opportunity Number: PAR-25-075

Agency: National Institutes of Health

Open Date: October 15, 2024

Close Date: October 14, 2026

Status: Posted

CFDA Numbers: 93.394

Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required)

Deadline: July 14, 2026


Opportunity Number: PAR-24-276

Agency: National Institutes of Health

Open Date: October 15, 2024

Close Date: July 14, 2026

Status: Posted

CFDA Numbers: 93.213

Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UH3 Clinical Trial Required)

Deadline: January 6, 2028


Opportunity Number: PAR-25-062

Agency: National Institutes of Health

Open Date: October 10, 2024

Close Date: January 6, 2028

Status: Posted

CFDA Numbers: 93.121

Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)

Deadline: January 7, 2027


Opportunity Number: PAR-25-098

Agency: National Institutes of Health

Open Date: October 10, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.399, 93.307, 93.121, 93.313

Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)

Deadline: October 14, 2026


Opportunity Number: PAR-24-304

Agency: National Institutes of Health

Open Date: October 10, 2024

Close Date: October 14, 2026

Status: Posted

CFDA Numbers: 93.394

Occupational Safety and Health Education and Research Centers (T42)

Deadline: October 26, 2028


Opportunity Number: RFA-OH-25-002

Agency: Centers for Disease Control and Prevention - ERA

Open Date: October 7, 2024

Close Date: October 26, 2028

Status: Posted

CFDA Numbers: 93.262

Limited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PA-25-093

Agency: National Institutes of Health

Open Date: October 4, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.855, 93.846

Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders(U01 Clinical Trial Optional)

Deadline: June 22, 2026


Opportunity Number: PAR-25-050

Agency: National Institutes of Health

Open Date: October 2, 2024

Close Date: June 22, 2026

Status: Posted

CFDA Numbers: 93.853

Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional)

Deadline: June 22, 2026


Opportunity Number: PAR-25-055

Agency: National Institutes of Health

Open Date: October 2, 2024

Close Date: June 22, 2026

Status: Posted

CFDA Numbers: 93.853

Research Experiences and/or Mentoring Networks through Research Education to Enhance Clinician-Scientists' Participation in NIDCDs Research (R25 Clinical Trial Not Allowed)

Deadline: September 29, 2027


Opportunity Number: PAR-25-020

Agency: National Institutes of Health

Open Date: October 2, 2024

Close Date: September 29, 2027

Status: Posted

CFDA Numbers: 93.173

SEEDING CRITICAL ADVANCES FOR LEADING ENERGY TECHNOLOGIES WITH UNTAPPED POTENTIAL (SCALEUP) READY

Deadline: September 29, 2029


Opportunity Number: DE-FOA-0003467

Agency: Advanced Research Projects Agency Energy

Open Date: October 2, 2024

Close Date: September 29, 2029

Status: Posted

CFDA Numbers: 81.135

Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

Deadline: August 18, 2027


Opportunity Number: PAR-24-293

Agency: National Institutes of Health

Open Date: October 1, 2024

Close Date: August 18, 2027

Status: Posted

CFDA Numbers: 93.121, 93.867, 93.279, 93.242, 93.113, 93.853, 93.273, 93.213, 93.866

Fundamental Research to Counter Weapons of Mass Destruction

Deadline: September 30, 2034


Opportunity Number: HDTRA1-25-S-0001

Agency: Defense Threat Reduction Agency

Open Date: October 1, 2024

Close Date: September 30, 2034

Status: Posted

CFDA Numbers: 12.351

NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)

Deadline: September 7, 2027


Opportunity Number: PA-25-080

Agency: National Institutes of Health

Open Date: October 1, 2024

Close Date: September 7, 2027

Status: Posted

CFDA Numbers: 93.394, 93.867, 93.273, 93.859, 93.121, 93.310, 93.350, 93.853, 93.855, 93.233, 93.395, 93.837, 93.279, 93.393, 93.213, 93.172, 93.113, 93.846, 93.866, 93.838, 93.879, 93.839, 93.286, 93.399, 93.361, 93.242, 93.396, 93.840

Mitochondrial-associated Mechanisms of Neuropathological and Immunodeficient Aging in the Context of HIV and SUD (R01 Clinical Trials Not Allowed)

Deadline: March 10, 2026


Opportunity Number: RFA-DA-26-009

Agency: National Institutes of Health

Open Date: September 30, 2024

Close Date: March 10, 2026

Status: Posted

CFDA Numbers: 93.279

Mitochondrial-associated Mechanisms of Neuropathological and Immunodeficient Aging in the Context of HIV and SUD (R21 Clinical Trials Not Allowed)

Deadline: March 10, 2026


Opportunity Number: RFA-DA-26-010

Agency: National Institutes of Health

Open Date: September 30, 2024

Close Date: March 10, 2026

Status: Posted

CFDA Numbers: 93.279

Atmosphere Cluster

No deadline specified


Opportunity Number: PD-24-7790

Agency: U.S. National Science Foundation

Open Date: September 26, 2024

Status: Posted

CFDA Numbers: 47.050

Geospace Cluster

No deadline specified


Opportunity Number: PD-24-7789

Agency: U.S. National Science Foundation

Open Date: September 26, 2024

Status: Posted

CFDA Numbers: 47.050

Infrastructure Cluster

No deadline specified


Opportunity Number: PD-24-7791

Agency: U.S. National Science Foundation

Open Date: September 26, 2024

Status: Posted

CFDA Numbers: 47.050

BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)

Deadline: June 15, 2027


Opportunity Number: RFA-MH-26-120

Agency: National Institutes of Health

Open Date: September 25, 2024

Close Date: June 15, 2027

Status: Posted

CFDA Numbers: 93.213, 93.867, 93.853, 93.286, 93.865, 93.242, 93.279, 93.273, 93.866, 93.173

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

Deadline: August 18, 2026


Opportunity Number: PAR-25-051

Agency: National Institutes of Health

Open Date: September 25, 2024

Close Date: August 18, 2026

Status: Posted

CFDA Numbers: 93.121, 93.867, 93.279, 93.853, 93.242, 93.273, 93.213, 93.866

BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed)

Deadline: January 20, 2026


Opportunity Number: RFA-NS-25-018

Agency: National Institutes of Health

Open Date: September 24, 2024

Close Date: January 20, 2026

Status: Posted

CFDA Numbers: 93.173, 93.242, 93.853, 93.867, 93.279, 93.866, 93.273, 93.213, 93.865, 93.286

BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed)

Deadline: January 20, 2026


Opportunity Number: RFA-NS-25-017

Agency: National Institutes of Health

Open Date: September 24, 2024

Close Date: January 20, 2026

Status: Posted

CFDA Numbers: 93.865, 93.273, 93.213, 93.286, 93.853, 93.173, 93.866, 93.242, 93.279, 93.867

×

Request Grant Writing Assistance from GTC 360° Advisors

Our expert team at GTC 360° Advisors can help develop your grant strategy, recruit partner organizations, write your full proposal, compile and manage your budgets, and help you submit a compelling and compliant proposal on time.